Live Breaking News & Updates on Brussels Stock Exchange Hyl

Stay updated with breaking news from Brussels stock exchange hyl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Hyloris and Purna Female Healthcare Announce Positive

Hyloris and Purna Female Healthcare Announce Positive Results from Phase 2 Trial in Patients with Acute Vulvovaginal Candidiasis (VVC) Both treatment arms. ....

Jean Luc Vandebroek , Miconazole Domiphen , Stijn Van Rompay , Hyloris Pharmaceuticals Sa Euronext Brussels , Purna Pharmaceuticals , Hyloris Pharmaceuticals , Purna Female Healthcare Announce Positive Results , Acute Vulvovaginal Candidiasis , Domiphen Bromide , Euronext Brussels , Miconazole Domiphen Bromide , Van Rompay , Chief Executive Officer , Female Healthcare , Luc Vandebroek , Lancet Infectious Diseases , Clinical Infectious Diseases , Expert Opinion , Brussels Stock Exchange Hyl , Hyloris Pharmaceuticals Sa , Phase 2 , Positive Results , Emale Healtcare , Purna Female Healthcare ,

Hyloris announces submission of Maxigesic® IV packaging

Additional extractable & leachable data generated by an accredited lab facility located in North AmericaResults analyzed and evaluated by toxicological. ....

United States , Sven Watthy , Stijn Van Rompay , Jean Luc Vandebroek , Hyloris Pharmaceuticals Sa Euronext Brussels , Hyloris Pharmaceuticals , Food Drug Administration , Investor Relations Communications , Hikma Pharmaceuticals , Euronext Brussels , Drug Administration , Complete Response Letter , Van Rompay , Chief Executive Officer , Luc Vandebroek , Investor Relations , Persistent Opioid Use After Minor , Major Surgical Procedures , Brussels Stock Exchange Hyl , Hyloris Pharmaceuticals Sa , Axigesic Iv ,

Hyloris Announces Commercial Partnership for Maxigesic® IV

Exclusive licensing and distribution agreement signed with Salus Pharmaceuticals in Lithuania, Estonia, Latvia, Croatia, Slovenia, Serbia, North Macedonia,. ....

Sven Watthy , Pharma Gmb , Stijn Van Rompay , Jean Luc Vandebroek , November Maxigesic , Hyloris Pharmaceuticals Sa Euronext Brussels , Salus Pharmaceuticals , Hyloris Pharmaceuticals , Salus Pharmaceuticals For Maxigesic , Investor Relations Communications , North Macedonia , Euronext Brussels , Kever Pharma , Van Rompay , Chief Executive Officer , Luc Vandebroek , Investor Relations , Brussels Stock Exchange Hyl , Hyloris Pharmaceuticals Sa , Unmet Medical Need , Commercial Agreement ,

UPDATE – Hyloris Launches Equity Offering by Means of a

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER. ....

United States , United Kingdom , South Africa , Belgian Companies , European Parliament , Gossler Co , Hyloris Pharmaceuticals , European Union Withdrawal Agreement , Swiss Federal Act On Financial Services Finanzdienstleistungsgesetz , Stifel Nicolaus Europe Limited , Belgian Code Of Companies , Hyloris Pharmaceuticals Sa Euronext Brussels , European Union Withdrawal , Company The Committee , Association Code , Company Or Hyloris , Euronext Brussels , Joint Global Coordinators , Joint Bookrunners , Noshaq Partners , Belgian Code , Qualified Investors , Professional Clients , United Kingdom Relevant Persons , United States Securities Act , Member State ,

Correcting -- Hyloris reports results for the full year

Added 4 additional innovative product candidates Strong growth in H2 leading to total revenues of €3.1 million (€0.2 million in 2020) Significant. ....

United Kingdom , New Zealand , South Korea , Abid Irshad , Thomas Jacobsen , Vaneltix Pharma , Vulvovaginal Candidiasis , Stijn Van Rompay , Jean Luc Vandebroek , Chris Buyse , Academic Pharmaceuticals , Delveinsight Market Research , Hyloris Pharmaceuticals Sa Euronext Brussels , Department Of Radiology , University Of South Carolina College Medicine , Leukemia Lymphoma Society , Business Development , Euronext Brussels , Chief Executive Officer , Delveinsight Market , Domiphen Bromide , Purna Female Healthcare , Recurrent Vulvovaginal Candidiasis , Pleco Therapeutics , Healthcare April , Lymphoma Society ,